Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment

Rare diseases, especially monogenic diseases, which usually affect a single target protein, have attracted growing interest in drug research by encouraging pharmaceutical companies to design and develop therapeutic products to be tested in the clinical arena. Acute intermittent porphyria (AIP) is on...

Descripción completa

Detalles Bibliográficos
Autores principales: Jericó, Daniel, Córdoba, Karol M., Sampedro, Ana, Jiang, Lei, Joucla, Gilles, Cabanne, Charlotte, Lanciego, José Luis, Martini, Paolo G. V., Berraondo, Pedro, Ávila, Matías A., Fontanellas, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694773/
https://www.ncbi.nlm.nih.gov/pubmed/36430993
http://dx.doi.org/10.3390/life12111858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694773/
https://www.ncbi.nlm.nih.gov/pubmed/36430993
http://dx.doi.org/10.3390/life12111858

Ejemplares similares